/f/125658/4252x1496/43d16b540f/ehra-acronym-name-rgb.png)
Early rhythm control in patients with recently diagnosed atrial fibrillation: findings from the GLORIA-AF Registry Phase III
Event: EHRA 2024
Topic: Treatment
Session: Atrial fibrillation: clinical
Mobile health technology integrated care in atrial fibrillation patients according to atrial fibrillation subtype: a subgroup analysis of the mAFA-II randomised trial
Event: ESC Congress 2023
Topic: Clinical
Session: From mobile health technology to clinical issues in atrial fibrillation
The effect of a mobile health technology integrated care across multimorbidity patterns in atrial fibrillation patients: a latent-class ancillary analysis from the mAFA-II randomised clinical trial
Event: ESC Congress 2023
Topic: Clinical
Session: From mobile health technology to clinical issues in atrial fibrillation
Educational level and risk of all-cause death in patients with heart failure with reduced ejection fraction (HFrEF): a report from the WARCEF Trial
Event: ESC Congress 2023
Topic: Epidemiology, Prognosis, Outcome
Session: Outcomes in heart failure
Adverse outcomes according to metabolic status in obese and overweight patients with atrial fibrillation: a report from the GLORIA-AF Phase II and III Registry
Event: ESC Congress 2023
Topic: Epidemiology, Prognosis, Outcome
Session: Risk factors and outcome in patients with atrial fibrillation
New-onset atrial fibrillation in patients with community-acquired pneumonia: a systematic review and meta-analysis
Event: ESC Congress 2022
Topic: Prevalence and Incidence of Atrial Fibrillation
Session: Atrial fibrillation and concomitant medical conditions
Cerebral microbleeds and risk of adverse outcomes in patients with atrial fibrillation: a systematic review and meta-analysis
Event: ESC Congress 2021 - The Digital Experience
Topic: Epidemiology, Prognosis, Outcome
Session: Atrial fibrillation e-posters
ESC 365 is supported by
